Patient profiling in diabetes and role of canagliflozin
Ambika Amblee1,2 1Division of Endocrinology, John H Stroger Jr Hospital of Cook County, 2Rush University Medical Center, Chicago, IL, USA Background: Physicians attempt to achieve glycemic goals in patients with type 2 diabetes mellitus (T2DM) through various means, including glucose-lowering medica...
Saved in:
Main Author: | Amblee A (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2014-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Canagliflozin-Induced Diabetic Ketoacidosis
by: Jessica Turner MSIV, et al.
Published: (2016) -
Canagliflozin and risk of amputation in patients with type 2 diabetes
by: T. M. Bukatina, et al.
Published: (2018) -
Emerging treatments in type 2 diabetes: focus on canagliflozin
by: Rosiak M, et al.
Published: (2014) -
Canagliflozin - Beginning of the journey
by: Sunil Kumar Pandey, et al.
Published: (2014) -
Canagliflozin: a novel treatment option for type 2 diabetes
by: Dietrich E, et al.
Published: (2013)